PRL3-zumab, a first-in-class humanized antibody for cancer therapy.
Thura M, Al-Aidaroos AQO, Yong WP, Kono K, Gupta A, Lin YB, Mimura K, Thiery JP, Goh BC, Tan P, Soo R, Hong CW, Wang L, Lin SJ, Chen E, Rha SY, Chung HC, Li J, Nandi S, Yuen HF, Zhang SD, Guan YK, So J, Zeng Q.
Thura M, et al. Among authors: al aidaroos aqo.
JCI Insight. 2016 Jun 16;1(9):e87607. doi: 10.1172/jci.insight.87607.
JCI Insight. 2016.
PMID: 27699276
Free PMC article.